Moreover, using a xenograft assay, Bacelli et al. demonstrated that CTCs with a tumor-initiating phenotype (CD45−, EpCAM+, CD44+, CD47+, MET+) can produce metastases [109]. Here, EPCAM is linked to neoplasm.